Global Oligonucleotides Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112230031 | Category: Pharma & Healthcare | Pages: 112 | Format: PDF | Published Date: November 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oligonucleotides market size is estimated to be worth US$ 1290.3 million in 2021 and is forecast to a readjusted size of USD 2461.4 million by 2028 with a CAGR of 9.7% during review period. Pharmaceutical accounting for  % of the Oligonucleotides global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While DNA Oligos segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Oligonucleotides include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, and L.G.C Biosearch Technologies, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Oligonucleotides market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    DNA Oligos
    RNA Oligos
Market segment by Application, can be divided into
    Pharmaceutical
    Research
    Diagnostic
Market segment by players, this report covers
    Integrated DNA Technologies
    Agilent
    Sigma-aldrich
    Eurofins Genomics
    L.G.C Biosearch Technologies
    Eurogentec S.A
    Nitto Denko Avecia Inc
    GenScript
    BBI Life Sciences
    GeneDesign
    TriLink BioTechnologies
    SGS DNA
    LC Sciences
    Twist Bioscience
    Creative Biogene
    General Biosystems
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oligonucleotides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oligonucleotides, with revenue, gross margin and global market share of Oligonucleotides from 2019 to 2022.
Chapter 3, the Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oligonucleotides market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Oligonucleotides research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Oligonucleotides
    1.2 Classification of Oligonucleotides by Type
        1.2.1 Overview: Global Oligonucleotides Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Oligonucleotides Revenue Market Share by Type in 2021
        1.2.3 DNA Oligos
        1.2.4 RNA Oligos
    1.3 Global Oligonucleotides Market by Application
        1.3.1 Overview: Global Oligonucleotides Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Pharmaceutical
        1.3.3 Research
        1.3.4 Diagnostic
    1.4 Global Oligonucleotides Market Size & Forecast
    1.5 Global Oligonucleotides Market Size and Forecast by Region
        1.5.1 Global Oligonucleotides Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Oligonucleotides Market Size by Region, (2017-2022)
        1.5.3 North America Oligonucleotides Market Size and Prospect (2017-2028)
        1.5.4 Europe Oligonucleotides Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Oligonucleotides Market Size and Prospect (2017-2028)
        1.5.6 South America Oligonucleotides Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Oligonucleotides Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Oligonucleotides Market Drivers
        1.6.2 Oligonucleotides Market Restraints
        1.6.3 Oligonucleotides Trends Analysis
2 Company Profiles
    2.1 Integrated DNA Technologies
        2.1.1 Integrated DNA Technologies Details
        2.1.2 Integrated DNA Technologies Major Business
        2.1.3 Integrated DNA Technologies Oligonucleotides Product and Solutions
        2.1.4 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Integrated DNA Technologies Recent Developments and Future Plans
    2.2 Agilent
        2.2.1 Agilent Details
        2.2.2 Agilent Major Business
        2.2.3 Agilent Oligonucleotides Product and Solutions
        2.2.4 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Agilent Recent Developments and Future Plans
    2.3 Sigma-aldrich
        2.3.1 Sigma-aldrich Details
        2.3.2 Sigma-aldrich Major Business
        2.3.3 Sigma-aldrich Oligonucleotides Product and Solutions
        2.3.4 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Sigma-aldrich Recent Developments and Future Plans
    2.4 Eurofins Genomics
        2.4.1 Eurofins Genomics Details
        2.4.2 Eurofins Genomics Major Business
        2.4.3 Eurofins Genomics Oligonucleotides Product and Solutions
        2.4.4 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Eurofins Genomics Recent Developments and Future Plans
    2.5 L.G.C Biosearch Technologies
        2.5.1 L.G.C Biosearch Technologies Details
        2.5.2 L.G.C Biosearch Technologies Major Business
        2.5.3 L.G.C Biosearch Technologies Oligonucleotides Product and Solutions
        2.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 L.G.C Biosearch Technologies Recent Developments and Future Plans
    2.6 Eurogentec S.A
        2.6.1 Eurogentec S.A Details
        2.6.2 Eurogentec S.A Major Business
        2.6.3 Eurogentec S.A Oligonucleotides Product and Solutions
        2.6.4 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Eurogentec S.A Recent Developments and Future Plans
    2.7 Nitto Denko Avecia Inc
        2.7.1 Nitto Denko Avecia Inc Details
        2.7.2 Nitto Denko Avecia Inc Major Business
        2.7.3 Nitto Denko Avecia Inc Oligonucleotides Product and Solutions
        2.7.4 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Nitto Denko Avecia Inc Recent Developments and Future Plans
    2.8 GenScript
        2.8.1 GenScript Details
        2.8.2 GenScript Major Business
        2.8.3 GenScript Oligonucleotides Product and Solutions
        2.8.4 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 GenScript Recent Developments and Future Plans
    2.9 BBI Life Sciences
        2.9.1 BBI Life Sciences Details
        2.9.2 BBI Life Sciences Major Business
        2.9.3 BBI Life Sciences Oligonucleotides Product and Solutions
        2.9.4 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 BBI Life Sciences Recent Developments and Future Plans
    2.10 GeneDesign 
        2.10.1 GeneDesign Details
        2.10.2 GeneDesign Major Business
        2.10.3 GeneDesign Oligonucleotides Product and Solutions
        2.10.4 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 GeneDesign Recent Developments and Future Plans
    2.11 TriLink BioTechnologies
        2.11.1 TriLink BioTechnologies Details
        2.11.2 TriLink BioTechnologies Major Business
        2.11.3 TriLink BioTechnologies Oligonucleotides Product and Solutions
        2.11.4 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 TriLink BioTechnologies Recent Developments and Future Plans
    2.12 SGS DNA
        2.12.1 SGS DNA Details
        2.12.2 SGS DNA Major Business
        2.12.3 SGS DNA Oligonucleotides Product and Solutions
        2.12.4 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 SGS DNA Recent Developments and Future Plans
    2.13 LC Sciences
        2.13.1 LC Sciences Details
        2.13.2 LC Sciences Major Business
        2.13.3 LC Sciences Oligonucleotides Product and Solutions
        2.13.4 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 LC Sciences Recent Developments and Future Plans
    2.14 Twist Bioscience
        2.14.1 Twist Bioscience Details
        2.14.2 Twist Bioscience Major Business
        2.14.3 Twist Bioscience Oligonucleotides Product and Solutions
        2.14.4 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Twist Bioscience Recent Developments and Future Plans
    2.15 Creative Biogene
        2.15.1 Creative Biogene Details
        2.15.2 Creative Biogene Major Business
        2.15.3 Creative Biogene Oligonucleotides Product and Solutions
        2.15.4 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Creative Biogene Recent Developments and Future Plans
    2.16 General Biosystems
        2.16.1 General Biosystems Details
        2.16.2 General Biosystems Major Business
        2.16.3 General Biosystems Oligonucleotides Product and Solutions
        2.16.4 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 General Biosystems Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Oligonucleotides Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Oligonucleotides Players Market Share in 2021
        3.2.2 Top 10 Oligonucleotides Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Oligonucleotides Players Head Office, Products and Services Provided
    3.4 Oligonucleotides Mergers & Acquisitions
    3.5 Oligonucleotides New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Oligonucleotides Revenue and Market Share by Type (2017-2022)
    4.2 Global Oligonucleotides Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Oligonucleotides Revenue Market Share by Application (2017-2022)
    5.2 Global Oligonucleotides Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Oligonucleotides Revenue by Type (2017-2028)
    6.2 North America Oligonucleotides Revenue by Application (2017-2028)
    6.3 North America Oligonucleotides Market Size by Country
        6.3.1 North America Oligonucleotides Revenue by Country (2017-2028)
        6.3.2 United States Oligonucleotides Market Size and Forecast (2017-2028)
        6.3.3 Canada Oligonucleotides Market Size and Forecast (2017-2028)
        6.3.4 Mexico Oligonucleotides Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Oligonucleotides Revenue by Type (2017-2028)
    7.2 Europe Oligonucleotides Revenue by Application (2017-2028)
    7.3 Europe Oligonucleotides Market Size by Country
        7.3.1 Europe Oligonucleotides Revenue by Country (2017-2028)
        7.3.2 Germany Oligonucleotides Market Size and Forecast (2017-2028)
        7.3.3 France Oligonucleotides Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Oligonucleotides Market Size and Forecast (2017-2028)
        7.3.5 Russia Oligonucleotides Market Size and Forecast (2017-2028)
        7.3.6 Italy Oligonucleotides Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Oligonucleotides Revenue by Type (2017-2028)
    8.2 Asia-Pacific Oligonucleotides Revenue by Application (2017-2028)
    8.3 Asia-Pacific Oligonucleotides Market Size by Region
        8.3.1 Asia-Pacific Oligonucleotides Revenue by Region (2017-2028)
        8.3.2 China Oligonucleotides Market Size and Forecast (2017-2028)
        8.3.3 Japan Oligonucleotides Market Size and Forecast (2017-2028)
        8.3.4 South Korea Oligonucleotides Market Size and Forecast (2017-2028)
        8.3.5 India Oligonucleotides Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Oligonucleotides Market Size and Forecast (2017-2028)
        8.3.7 Australia Oligonucleotides Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Oligonucleotides Revenue by Type (2017-2028)
    9.2 South America Oligonucleotides Revenue by Application (2017-2028)
    9.3 South America Oligonucleotides Market Size by Country
        9.3.1 South America Oligonucleotides Revenue by Country (2017-2028)
        9.3.2 Brazil Oligonucleotides Market Size and Forecast (2017-2028)
        9.3.3 Argentina Oligonucleotides Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Oligonucleotides Revenue by Type (2017-2028)
    10.2 Middle East & Africa Oligonucleotides Revenue by Application (2017-2028)
    10.3 Middle East & Africa Oligonucleotides Market Size by Country
        10.3.1 Middle East & Africa Oligonucleotides Revenue by Country (2017-2028)
        10.3.2 Turkey Oligonucleotides Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Oligonucleotides Market Size and Forecast (2017-2028)
        10.3.4 UAE Oligonucleotides Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Oligonucleotides Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?